Delivery Order SPE2DR25D3004-SPE2DR26FXTV7
- Not listed
- The Defense Logistics Agency awarded a $26,870.53 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,172.61 to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This firm fixed-price delivery order, with an ultimate completion date of December 16, 2025, was competitively awarded with no set-aside designation. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency awarded a $39,043.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count). This non-competitive delivery order is scheduled for completion by December 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $27,876.13 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder (60-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of December 15, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,375.39 on May 27, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-dose units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 28, 2025, representing a single pharmaceutical delivery to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,702.52 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by January 7, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $20,734.05 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder in a 60-dose configuration. This competitive, firm fixed-price contract will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by January 7, 2026. The award carries no set-aside designation, indicating it was competed on a full and open basis. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $30,851.70 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 3, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,511.28 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalation powder (60-count units) on January 8, 2026. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 9, 2026. The award represents a task order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,852.11 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This competitively awarded, firm fixed-price delivery order is not set aside and is scheduled for completion by January 14, 2026. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXTV7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $25,562.32 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder with a 60-dose capacity. This firm fixed-price, competitively awarded delivery order is set to be completed by January 14, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide. Through this strategic contracting vehicle, AmerisourceBergen serves multiple government healthcare systems including the Defense Health Agency and U.S. Coast Guard, demonstrating the company's established capability to fulfill federal pharmaceutical procurement requirements at scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.6k | 1/12/26 |